These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1814756)

  • 21. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
    Schumacher WA; Steinbacher TE
    J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of verapamil upon ouabain-induced cardiac arrhythmias.
    Khatter JC; Navaratnam S; Hoeschen RJ
    Pharmacology; 1988; 36(6):380-9. PubMed ID: 3420160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
    Flores NA; Goulielmos NV; Seghatchian MJ; Sheridan DJ
    Cardiovasc Res; 1994 Nov; 28(11):1662-71. PubMed ID: 7842460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs.
    Komatsu H; Takehana Y; Kikuchi S; Kojima M; Hamano S; Kusama H; Okegawa T; Ikeda S
    Eur J Pharmacol; 1990 Aug; 184(1):87-95. PubMed ID: 2170151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon.
    Suzuki T; Sakai H; Takeguchi N
    Eur J Pharmacol; 2000 Jul; 400(2-3):297-303. PubMed ID: 10988347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of thromboxane synthase and cyclooxygenase inhibition on PAF-induced changes in lung function and arachidonic acid metabolism.
    Trochtenberg DS; Lefferts PL; King GA; Hwang YS; Christman BW; Snapper JR
    Prostaglandins; 1992 Dec; 44(6):555-77. PubMed ID: 1475377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs.
    Qian C; Guo ZM; Peters CJ; Liu CT
    J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs.
    Kato M; Tokuyama K; Morikawa A; Kuroume T; Barnes PJ
    Eur J Pharmacol; 1993 Feb; 232(1):7-12. PubMed ID: 8384564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
    Handley DA; Lee ML; Saunders RN
    Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thromboxane synthetase inhibitor (UK 38,485) and thromboxane receptor antagonist (ICI 185,282) on digoxin-induced arrhythmias in anaesthetized guinea-pigs.
    Kanzik I; Demiryürek AT; Zengil H; Abacioğlu N; Dörtlemez H
    Clin Exp Pharmacol Physiol; 1988 Dec; 15(12):927-35. PubMed ID: 3243019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective action of methyldopa against ouabain-induced cardiac arrhythmias and lethality.
    Thomas GP; Stephen PM
    Arch Int Pharmacodyn Ther; 1993; 323():23-31. PubMed ID: 8250641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
    Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea-pigs.
    Thomas GP; Stephen PM
    Br J Pharmacol; 1991 Dec; 104(4):995-9. PubMed ID: 1687372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and reversal of ouabain-induced cardiotoxicity by naloxone in the guinea-pig.
    Lee AY; Unang TW; Wong TM
    Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):55-8. PubMed ID: 3708913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric mucosal protection with selective inhibition of thromboxane synthesis.
    Walt RP; Kemp RT; Filipowicz B; Davies JG; Bhaskar NK; Hawkey CJ
    Gut; 1987 May; 28(5):541-4. PubMed ID: 3474195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
    Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective action of cimetidine against ouabain-induced pressor effects, arrhythmias, and lethality in guinea pigs.
    Trzeciakowski JP
    J Cardiovasc Pharmacol; 1985; 7(4):622-9. PubMed ID: 2410699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
    Smallbone BW; Taylor NE; McDonald JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1035-40. PubMed ID: 2821222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.